Ore Pharmaceutical Holdings Inc.
http://www.orepharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ore Pharmaceutical Holdings Inc.
Asia Deal Watch: China Grand, ETheRNA Create mRNA Vaccine JV
Plus deals involving LegoChem/Pyxix, Biohaven/Sosei Heptares, Kyowa Kirin/Helsinn, Dr. Reddy’s/Glenmark, Eisai/Wren, KoBioLabs/Kolmar Korea, Y-Biologics/Pierre Fabre, Generex/Chinese consortium.
KoBioLabs Sees IPO Building Its Credentials As Global Microbiome Player
The Korean microbiome therapeutics developer KoBioLabs will launch a domestic IPO later this month and hopes to grow into a top three global company in the sector by 2025, helped by licensing deals.
Scorpion Nabs $108m, Biopharma Veterans For Precision Oncology 2.0
The company has assembled small molecule discovery capabilities for the development of targeted cancer drugs that it believes rivals big pharma efforts and will fulfill patients’ unmet needs.
Drug-Coated Balloon For Urethral Strictures Debuts In Europe, Version For BPH Planned
Urotronic set to complete a $20m series C, bringing its total funding to $61m for the development of drug-eluting balloon-based urology products.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Gene Logic Inc.
- Ore Holdings Inc.
- Ore Pharmaceuticals, Inc.